13
Aug

Rigel Pharmaceuticals’ just got a little thinner, as another failed clinical trial has dimmed its hopes in dry eye disease, the latest in a string of missteps for the biotech.

…read more

Source: Rigel endures another clinical setback as eye drug flunks Phase II

    

0 No comments